Drug · DIN 02492806 · Radiopharmaceutical
GALLI EO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 29, 2020; first marketed July 29, 2020.
- Drug Identification Number (DIN)
- 02492806
- Company (DIN owner)
- Ire Elit S.A.Fleurus, --, Belgium
- Schedule
- Schedule c
- Dosage form
- Solution
- Route
- 0-Unassigned
- Therapeutic class (ATC)
- Other diagnostic radiopharm. for tumor detection V09IX
- Class
- Radiopharmaceutical
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GALLIUM 68 Ga CHLORIDE | 1.85 GBQ | GEN |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 13, 2019: NOC 23094New Drug Submission (NDS)